+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Marginal Zone Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Marginal Zone Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Hemophagocytic Lymphohistiocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Hemophagocytic Lymphohistiocytosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
From
Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Phaeochromocytoma - Pipeline Insight, 2025 - Product Thumbnail Image

Phaeochromocytoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Acral Lentiginous Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Acral Lentiginous Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Aminopeptidase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Aminopeptidase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
TRAIL Receptor 2 Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRAIL Receptor 2 Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ERBB 2 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

ERBB 2 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
CD33 Antigen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

CD33 Antigen Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Notch Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Notch Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Discoidin Domain Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Discoidin Domain Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 96 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more